Cataract

The surgery isn't over until the healing is don

Of participants surveyed, 36% reported a fear of cataract surgery, with more than half of those specifically feared it would lead to vision loss.

The lens has been introduced to select practices across the US, with broad commercial availability planned for in May.

The grant will allow the research team to determine the novel mechanisms that convert immature eye lens precursors cells into functional transparent cells.

Cationic emulsion drops are characterized by their ability to retain cyclosporine A on the ocular surface.

Persistent ocular surface dysfunction after cataract surgery impacts patient satisfaction despite 20/20 vision, with pre-op screening and tailored care being key components.

A total of 150 placements are for aspiring optometrists to shadow SpaMedica’s clinical teams and in-house optometrists as they treat patients.

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

The ELIOS system is a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery.

The primary endpoint of the 4-month study was the proportion of patients with clinically significant improvements in the contrast sensitivity.

Study investigators found that the injuries ranged from deep thermal burns to full-thickness corneal or scleral lacerations, with one case of traumatic cataract.

Removing drops improves adherence and comfort for most patients.

Adam Ramsey, OD, focused on managing patient expectations and addressing unmet outcomes during a featured symposium on key advances in cataract surgery at EyeCon 2023. He also previewed his upcoming lecture on utilizing virtual assistants to revolutionize the patient experience in eye care.

Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, FAAO, recap the diverse topics at EyeCon 2023, emphasizing the collaborative spirit between optometrists and ophthalmologists in addressing issues such as myopia management, diabetic eye conditions, cataract surgery, and patient referrals.

Even if DLS is completely normal and expected, it can be mentally and emotionally difficult for patients.

The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.

The financing will help advance the company’s novel treatment system for glaucoma and other chronic ophthalmic diseases.

Annual meeting places spotlight on newest clinical techniques, industry trends.

Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.

In this recent study, Bharti Nihalani-Gangwani, MD, and Deborah VanderVeen, MD, reported that 29% developed glaucoma in a large infant cohort and the risk factors at the American Society of Cataract and Refractive Surgery annual meeting in San Diego.

In a presentation at the American Society for Cataract and Refractive Surgery annual meeting in San Diego, Erisa Yotsukura, MD, PhD, offered details of a study examining an IOL that transmits violet light and a second option that does not, and they believe this can affect differences in the choroidal thickness after cataract surgery.

Mark Packer, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on machine learning and predicting vision outcomes after cataract surgery at the ASCRS annual meeting in San Diego.

New and returning special events and features on tap at annual meeting

The study found that pseudophakic children older at the time of surgery developed a glaucoma-related adverse event less frequently.

The aspheric, monofocal, single-piece C-loop IOL from Zeiss compensates for a range of spherical aberrations to minimize decentration and lens misalignments.

Researchers found that prompt intervention may improve the prognosis of fungal endophthalmitis caused by contaminated medical products.

Benefits include eliminating eyeglass problems and boosting patient confidence.

In the second deal between Harrow and Novartis, the former is expected to add 5 ophthalmic products to its portfolio.

The main outcome measures were the baseline cataract severity and self-reported cataract surgery at a 15-year visit.

As technology improves, less-invasive treatments save patients time and money.